Additionally, through further immunoblot analysis of tumor tissues, we observed that Formononetin treatment led to a reduction in the expression of intracellular ferroptosis-related proteins GPX4, and xCT (Figure 2K). The gene discussed is SLC7A11; the disease is neoplasm.